Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of neural transmission. Supplementum

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-211-45295-0_56PMID 17017555
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microglia Initiate Central Nervous System Innate and Adaptive Immune Responses through Multiple TLRs1

  2004cited by this paper
• NADPH Oxidase Mediates Lipopolysaccharide-induced Neurotoxicity and Proinflammatory Gene Expression in Activated Microglia*

  2004cited by this paper
• Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention

  2003cited by this paper
• Role of Nitric Oxide in Inflammation‐Mediated Neurodegeneration

  2002influential reference
• Interleukin-10 and the interleukin-10 receptor.

  2001cited by this paper
• Interleukin-10 Signaling Blocks Inhibitor of κB Kinase Activity and Nuclear Factor κB DNA Binding*

  1999cited by this paper
• Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding.

  1999cited by this paper
• The role of microglia and astrocytes in CNS immune surveillance and immunopathology.

  1999cited by this paper
• Microglia: a sensor for pathological events in the CNS.

  1996cited by this paper
• Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.

  1995cited by this paper
• Production of interleukin-10 by mouse glial cells in culture.

  1994cited by this paper
• Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

  1993cited by this paper

• Immunity in Parkinson's disease - The role of innate responses.

  2025cites this paper
• Neuro-immune interactions in coronary microvascular disease: mechanisms and therapeutic prospect

  2025cites this paper
• The prognostic and predictive value of peripheral immune-related proteins in patients with lung cancer treated with radiotherapy

  2025cites this paper
• Under the umbrella of depression and Alzheimer's disease physiopathology: can cannabinoids be a dual-pleiotropic therapy?

  2023cites this paper
• Dietary Supplementation With Tinospora cordifolia Improves Anxiety-Type Behavior and Cognitive Impairments in Middle-Aged Acyclic Female Rats

  2022cites this paper
• Regulation of the Human IL-10RB Gene Expression by Sp8 and Sp9

  2022cites this paper
• Possible Neuropathology of Sleep Disturbance Linking to Alzheimer’s Disease: Astrocytic and Microglial Roles

  2022cites this paper
• Design, synthesis and biological evaluation of novel antipyrine based α-aminophosphonates as anti-Alzheimer and anti-inflammatory agent

  2021cites this paper
• Genetic association study reveals impact of interleukin 10 polymorphisms on cognitive functions in schizophrenia.

  2021cites this paper
• Early low-dose ghrelin intervention via miniosmotic pumps could protect against the progressive dopaminergic neuron loss in Parkinson's disease mice.

  2021cites this paper
• The Anti-inflammatory Effect of the Tricyclic Antidepressant Clomipramine and Its High Penetration in the Brain Might Be Useful to Prevent the Psychiatric Consequences of SARS-CoV-2 Infection

  2021cites this paper
• Early ghrelin intervention protects against the progressive dopaminergic neuron loss in Parkinson’s disease mice

  2020cites this paper
• Early low-dose ghrelin intervention via mini-osmotic pumps could protect against the progressive dopaminergic neuron loss in Parkinson’s disease mice

  2020cites this paper
• Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease

  2020cites this paper
• The interactive effect of genetic polymorphisms of IL-10 and COMT on cognitive function in schizophrenia.

  2020cites this paper
• Appraisal of a neuroprotective consequence of Curcuma zedoaria Roxb. rhizomes on memory malfunction in oxidative tension convinced C6 glioma cells of rats

  2019cites this paper
• Mechanism underlying β2-AR agonist-mediated phenotypic conversion of LPS-activated microglial cells.

  2019cites this paper
• Neuronostatin promotes soluble A&bgr;1‐42 oligomers –induced spatial learning and memory impairments in mice

  2019cites this paper
• Dietary eicosapentaenoic acid normalizes hippocampal omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central interleukin-1β administration

  2018cites this paper
• β-arrestin2 regulates the anti-inflammatory effects of Salmeterol in lipopolysaccharide-stimulated BV2 cells.

  2018cites this paper
• Zingiber officinale extract pre-treatment ameliorates astrocytes activation and enhances neuroprotection in pentylenetetrazol-induced kindling model of epilepsy in mice

  2018cites this paper
• Particulate Matter Triggers Depressive-Like Response Associated With Modulation of Inflammatory Cytokine Homeostasis and Brain-Derived Neurotrophic Factor Signaling Pathway in Mice

  2018cites this paper
• Anthocyanins Improve Hippocampus-Dependent Memory Function and Prevent Neurodegeneration via JNK/Akt/GSK3β Signaling in LPS-Treated Adult Mice

  2018cites this paper
• Impact of aging immune system on neurodegeneration and potential immunotherapies

  2017cites this paper
• DHA, EPA and their combination at various ratios differently modulated Aβ25-35-induced neurotoxicity in SH-SY5Y cells.

  2017cites this paper
• The Contribution of the PDK1/Akt signaling pathway to Alzheimer disease analyzed by knock-in mutation

  2017influential citation
• High BMI levels associate with reduced mRNA expression of IL10 and increased mRNA expression of iNOS (NOS2) in human frontal cortex

  2017cites this paper
• Contribution of IL-10 and its -592 A/C polymorphism to cognitive functions in first-episode drug-naive schizophrenia.

  2016cites this paper
• Family-based association study of interleukin 10 (IL10) and interleukin 10 receptor alpha (IL10RA) functional polymorphisms in schizophrenia in Polish population.

  2016cites this paper
• Contribution des effets ciblés et non ciblés en radioimmunothérapie alpha et Auger de carcinoses péritonéales

  2016cites this paper
• Contributions of central and systemic inflammation to the pathophysiology of Parkinson ’ s disease

  2016cites this paper
• Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration

  2015influential citation
• The therapeutic potential of interleukin-10 in neuroimmune diseases.

  2015cites this paper
• Oxidized cholesterol as the driving force behind the development of Alzheimer’s disease

  2015cites this paper
• The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus.

  2015cites this paper
• Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition.

  2015cites this paper
• The impact of selected cytokines in the follow-up of normal pressure hydrocephalus.

  2015cites this paper
• Contrôle de l'activation microgliale par les lymphocytes T dans un modèle murin de neurodégénérescence induite par la 6-OHDA

  2014cites this paper
• The cellular and genomic response of rat dopaminergic neurons (N27) to coated nanosilver.

  2014cites this paper
• The influence of AAV2-mediated gene transfer of human IL-10 on neurodegeneration and immune response in a murine model of Parkinson’s disease

  2014cites this paper
• Neuroinflammation in Pulmonary Hypertension: Concept, Facts, and Relevance

  2014cites this paper
• Various Forms of Tissue Damage and Danger Signals Following Hematopoietic Stem-Cell Transplantation

  2014influential citation
• Selected pro- and anti-inflammatory cytokines in cerebrospinal fluid in normal pressure hydrocephalus.

  2014cites this paper
• Chronic meningeal inflammation as a cause of cortical grey matter pathology in multiple sclerosis

  2014cites this paper
• Review Article Immunity and inflammation in neurodegenerative diseases

  2013cites this paper
• Alpha-synuclein and its direct effects on microglial activation

  2013cites this paper
• Immunology primer for neurosurgeons and neurologists part 2: Innate brain immunity

  2013cites this paper
• Immunity and inflammation in neurodegenerative diseases.

  2013cites this paper
• Interleukin-10 inhibits angiotensin II-induced decrease in neuronal potassium current.

  2013cites this paper
• A friend in need may not be a friend indeed: role of microglia in neurodegenerative diseases.

  2013cites this paper
• Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease.

  2012cites this paper
• Glutamate potentiates lipopolysaccharide-stimulated interleukin-10 release from neonatal rat spinal cord astrocytes.

  2012cites this paper
• A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer's disease.

  2012cites this paper
• IMMUNE MECHANISMS ASSOCIATED TO NEUROINFLAMMATION IN ALZHEIMER'S DISEASE

  2012cites this paper
• Delirium in the elderly: biomarkers and outcomes

  2012cites this paper
• Interleukin-10 promoter polymorphisms in Chinese patients with Parkinson's disease.

  2012cites this paper
• Cytokines in Radiobiological Responses: A Review

  2012cites this paper
• Inflammation in Parkinson’s Disease: Causes and Consequences

  2012cites this paper
• Vitamin D and Parkinson's disease

  2012influential citation
• Cells, biomarkers, and post‐traumatic stress disorder: evidence for peripheral involvement in a central disease

  2012cites this paper
• Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression.

  2012cites this paper
• Vitamin D and Parkinson's disease.

  2012cites this paper
• Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein

  2012cites this paper
• Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer's disease.

  2011cites this paper
• α-Synuclein Alters Toll-Like Receptor Expression

  2011cites this paper
• Cross‐talk between human mesenchymal stem/progenitor cells (MSCs) and rat hippocampal slices in LPS‐stimulated cocultures: the MSCs are activated to secrete prostaglandin E2

  2011cites this paper
• Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection

  2011cites this paper
• The interleukin 10 promoter haplotype ACA and the long-form variant of the DRD4 uVNTR polymorphism are associated with vulnerability to schizophrenia.

  2011cites this paper
• Lipopolysaccharide-stimulated interleukin-10 release from neonatal spinal cord microglia is potentiated by glutamate.

  2011cites this paper
• Signaling pathways involved in the modulation of microglial reactivity by the action of GDNF

  2011cites this paper
• UvA-DARE ( Digital Academic Repository ) Delirium in the elderly : biomarkers and outcomes

  2011cites this paper
• Microglia: the physiology and its role in the aging brain

  2011cites this paper
• Neuroprotective effects of granulocyte‐colony stimulating factor in a novel transgenic mouse model of SCA17

  2011cites this paper
• Circulating interleukin‐10 and interleukin‐12 in Parkinson’s disease

  2009cites this paper
• 6-Hydroxycleroda-3,13-dien-15,16-olide Protects Neuronal Cells from Lipopolysaccharide-Induced Neurotoxicity through the Inhibition of Microglia-Mediated Inflammation

  2009cites this paper
• The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

  2009cites this paper
• The influence of microglia on the pathogenesis of Parkinson's disease.

  2009cites this paper
• Role of different cytokines and seizure susceptibility: a new dimension towards epilepsy research.

  2009cites this paper
• Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease.

  2008cites this paper
• Interactions of neurons, astrocytes and microglia with HUCB cell populations in stroke models: Migration, neuroprotection and inflammation

  2008cites this paper
• Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: Evidence for uncoupled regulation of mPGES‐1 and COX‐2

  2008cites this paper
• Inflammatory Aspects of Alzheimer Disease and Other Neurodegenerative Disorders

  2008cites this paper
• Gazing into the future: Parkinson's disease gene therapeutics to modify natural history.

  2008cites this paper
• The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery

  2008cites this paper
• Potent Anti-Inflammatory and Neuroprotective Effects of TGF-β1 Are Mediated through the Inhibition of ERK and p47phox-Ser345 Phosphorylation and Translocation in Microglia1

  2008cites this paper
• Microglial cells and Parkinson’s disease

  2008cites this paper
• PDEs as drug targets for CNS immune disorders.

  2008cites this paper
• THE EFFECT OF PPARγ ACTIVATION BY PIOGLITAZONE ON THE LIPOPOLYSACCHARIDE-INDUCED PGE 2 AND NO PRODUCTION: POTENTIALUNDERLYING ALTERATION OF SIGNALING TRANSDUCTION

  2008cites this paper
• NADPH oxidase inhibitor DPI is neuroprotective at femtomolar concentrations through inhibition of microglia over-activation.

  2007cites this paper
• Microglia: active sensor and versatile effector cells in the normal and pathologic brain

  2007cites this paper
• Neuroprotective Effects of Glyceryl Nonivamide against Microglia-Like Cells and 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Human Dopaminergic Neuroblastoma Cells

  2007cites this paper
• Parkinson’s Disease and Related Disorders

  2006cites this paper
• Early Environmental Origins of Neurodegenerative Disease in Later Life

  2005cites this paper
• Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia

  2005cites this paper